EuRBPDB

Note: to get the extension of tumor abbreviations.

Cancer Related Information
Basic Information

Cancer associated literatures

PID	Title	Article	Time	Author	Doi
22057681	The expression of PCNA, c-erbB-2, p53, ER and PR as well as atypical hyperplasia in tissues nearby the breast cancer.	J Mol Histol	2012 Feb	Jia Z	doi: 10.1007/s10735-011-9371-1
21501231	Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.	J Oral Pathol Med	2011 Oct	Kato K	doi: 10.1111/j.1600-0714.2011.01032.x
19130399	Analysis of pRb, p16INK4A proteins and proliferating antigens: PCNA, Ki-67 and MCM5 expression in aggressive fibromatosis (desmoid tumor).	Histol Histopathol	2009 Mar	Stalinska L	doi: 10.14670/HH-24.299.
24283290	Estrogen receptor α mediates proliferation of breast cancer MCF-7 cells via a p21/PCNA/E2F1-dependent pathway.	FEBS J	2014 Feb	Liao XH	doi: 10.1111/febs.12658
18256758	Expression of peripheral benzodiazepine receptor, PCNA, and caspase-3 in cells of skin melanoma and squamous cell carcinoma.	Bull Exp Biol Med	2007 Jul	Ruksha TG	-
26339416	Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones.	Int J Clin Exp Pathol	2015 Jul 1	Han YH	-
19885588	Effect of 5-ALA-PDT on VEGF and PCNA expression in human NPC-bearing nude mice.	Oncol Rep	2009 Dec	Xie Y	-
23527218	Novel interaction between proliferating cell nuclear antigen and HLA I on the surface of tumor cells inhibits NK cell function through NKp44.	PLoS One	2013	Horton NC	doi: 10.1371/journal.pone.0059552
20211058	[Effects of genistein on colon cancer cells in vitro and in vivo and its mechanism of action].	Zhonghua Zhong Liu Za Zhi	2010 Jan	Fan YZ	-
21424069	Immunohistochemical nuclear staining for p53, PCNA, Ki-67 and bcl-2 in different histologic variants of basal cell carcinoma.	Rom J Morphol Embryol	2011	Mateoiu C	-
18510217	[Relevance between clinical behavior and bionomical findings of acoustic neuromas].	Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi	2008 Feb	Yang SM	-
17982625	Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.	Oncol Rep	2007 Dec	Hu TH	-
16101161	Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.	Anticancer Res	2005 Sep-Oct	Yoshimatsu T	-
18072009	Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.	Exp Clin Endocrinol Diabetes	2008 Feb	Saeger W	-
29019895	The prognostic value of PCNA expression in patients with osteosarcoma: A meta-analysis of 16 studies.	Medicine (Baltimore)	2017 Oct	Wang X	doi: 10.1097/MD.0000000000008254.
14669354	Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis.	World J Gastroenterol	2003 Dec	Yue SQ	-
26731993	High Expression of IncRNA-PCNA-AS1 in Human Gastric Cancer and its Clinical Significances.	Clin Lab	2015	Dang Y	-
22556262	Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.	Cancer Res	2012 Jul 1	Takawa M	doi: 10.1158/0008-5472.CAN-11-3701
14612290	Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer.	Hepatobiliary Pancreat Dis Int	2002 May	Dang CX	-
19550124	Effect of diallyl disulfide on cell cycle arrest of human colon cancer SW480 cells.	Ai Zheng	2009 Feb	Liao QJ	-
22021614	Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.	J Immunol	2011 Dec 1	Rosental B	doi: 10.4049/jimmunol.1102267
16888766	The discovery of labile methyl esters on proliferating cell nuclear antigen by MS/MS.	Proteomics	2006 Sep	Hoelz DJ	-
16552335	Proliferating cell nuclear antigen, survivin, and CD34 expressions in pancreatic cancer and their correlation with hypoxia-inducible factor 1alpha.	Pancreas	2006 Mar	Wei H	-
18312749	Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.	Clin Invest Med	2008	Zhong W	-
22622474	Elevated levels of proliferating and recently migrated tumor-associated macrophages confer increased aggressiveness and worse outcomes in breast cancer.	Ann Surg Oncol	2012 Nov	Mukhtar RA	doi: 10.1245/s10434-012-2415-2
15033825	p53, Bcl-2, PCNA expression, and apoptotic rates during cervical tumorigenesis.	Ann N Y Acad Sci	2003 Dec	Astudillo H	-
12532471	Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer.	World J Gastroenterol	2003 Feb	Yue H	-
12452062	[Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior].	Ai Zheng	2002 Jun	Ji SQ	-
16124066	Expression of cell cycle regulator p57kip2, cyclinE protein and proliferating cell nuclear antigen in human pancreatic cancer: an immunohistochemical study.	World J Gastroenterol	2005 Aug 28	Yue H	-
21031434	Elevated expression of cancer-associated proliferating cell nuclear antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer.	Prostate	2011 May 15	Wang X	doi: 10.1002/pros.21291
24012694	Effects of polymorphisms in translesion DNA synthesis genes on lung cancer risk and prognosis in Chinese men.	Cancer Epidemiol	2013 Dec	Xu HL	doi: 10.1016/j.canep.2013.08.003
22238610	Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer.	PLoS One	2012	Zhao H	doi: 10.1371/journal.pone.0029416
19483288	[Multi-slice spiral CT pulmonary perfusion imaging and the expression of VEGF/PCNA in non-small cell lung cancer].	Zhong Nan Da Xue Xue Bao Yi Xue Ban	2009 May	Liu J	-
15967114	[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.	Neoplasia	2005 Apr	Mamede M	-
18279620	[Expression and significance of E-cadherin, CD44v6, and proliferating cell nuclear antigen in non-small cell lung cancer].	Ai Zheng	2008 Feb	Weng MX	-
20394503	Geldanamycin-induced PCNA degradation in isolated Hsp90 complex from cancer cells.	Cancer Invest	2010 Jul	Wang X	doi: 10.3109/07357901003630983.
19481339	Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.	Cancer Lett	2009 Nov 18	Masuo T	doi: 10.1016/j.canlet.2009.05.001
12088102	Expression of c-erbB-2 in node negative breast cancer does not correlate with estrogen receptor status, predictors of hormone responsiveness, or PCNA expression.	Neoplasma	2002	Kol??r Z	-
20350215	Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).	Pathology	2010 Apr	Karamitopoulou E	doi: 10.3109/00313021003631379.
23542172	The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer.	Oncogene	2014 Mar 13	Zhao H	doi: 10.1038/onc.2013.84
17927850	[Expression of sonic hedgehog, EGFR and PCNA proteins in pancreatic cancer and their correlations to cell proliferation].	Ai Zheng	2007 Sep	Hu WG	-
28348485	ECRG2 enhances the anti-cancer effects of cisplatin in cisplatin-resistant esophageal cancer cells via upregulation of p53 and downregulation of PCNA.	World J Gastroenterol	2017 Mar 14	Hou XF	doi: 10.3748/wjg.v23.i10.1796.
28814116	The dark side of the ring: role of the DNA sliding surface of PCNA.	Crit Rev Biochem Mol Biol	2017 Dec	De March M	doi: 10.1080/10409238.2017.1364218
28611525	Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.	World J Gastroenterol	2017 May 28	Hu L	doi: 10.3748/wjg.v23.i20.3721.

Differential Expression

Expression in 33 cancers

Mutations

Cancer	Chr	Position	Mutation Type	dbSNP	Protein-change	Allele Freq
BLCA	chr20	5117519	Missense_Mutation	novel	G178A	0.23
BLCA	chr20	5115511	Missense_Mutation	novel	F215C	0.09
BLCA	chr20	5117625	Missense_Mutation	NA	E143K	0.22
BLCA	chr20	5115337	Missense_Mutation	rs747916514	M244I	0.19
BLCA	chr20	5115519	Silent	novel	L212L	0.12
BRCA	chr20	5118649	Frame_Shift_Del	novel	*M116Kfs8**	0.19
BRCA	chr20	5119792	Missense_Mutation	novel	E3Q	0.17
BRCA	chr20	5115114	3'UTR	novel		0.31
BRCA	chr20	5119918	5'UTR	novel		0.19
CESC	chr20	5117478	Nonsense_Mutation	NA	E192*	0.37
CESC	chr20	5119600	Missense_Mutation	novel	A67P	0.12
CESC	chr20	5119902	5'UTR	novel		0.19
COAD	chr20	5118832	Missense_Mutation	NA	D86Y	0.34
COAD	chr20	5119591	Missense_Mutation	NA	V70M	0.46
COAD	chr20	5117471	Missense_Mutation	NA	A194V	0.23
GBM	chr20	5115263	3'UTR	novel		0.25
GBM	chr20	5117630	Missense_Mutation	novel	S141Y	0.22
HNSC	chr20	5115554	Missense_Mutation	novel	E201K	0.31
KICH	chr20	5118835	Missense_Mutation	novel	E85Q	0.52
KIRC	chr20	5118639	Missense_Mutation	NA	D120N	0.24
KIRC	chr20	5117590	Missense_Mutation	NA	I154M	0.3
KIRP	chr20	5115104	3'UTR	novel		0.63
LIHC	chr20	5115477	Silent	NA	T226T	0.44
LUAD	chr20	5115472	Missense_Mutation	novel	S228N	0.12
LUSC	chr20	5117567	Missense_Mutation	novel	C162Y	0.35
LUSC	chr20	5115487	Missense_Mutation	novel	S223L	0.35
LUSC	chr20	5117557	Silent	rs17350	D165D	0.24
PAAD	chr20	5119765	Missense_Mutation	novel	L12F	0.07
PRAD	chr20	5118768	Splice_Site	rs112672560	X107_splice	0.07
READ	chr20	5115129	3'UTR	novel		0.44
READ	chr20	5118821	Silent	NA	T89T	0.16
READ	chr20	5115338	Missense_Mutation	NA	M244R	0.44
SKCM	chr20	5118861	Missense_Mutation	rs760578899	S76F	0.24
SKCM	chr20	5119583	Silent	rs267605997	L72L	0.21
SKCM	chr20	5118667	Frame_Shift_Del	novel	*K110Sfs5**	0.32
SKCM	chr20	5118778	Missense_Mutation	NA	E104K	0.28
SKCM	chr20	5118675	Nonsense_Mutation	NA	Q108*	0.38
STAD	chr20	5118862	Missense_Mutation	NA	S76P	0.44
STAD	chr20	5115524	Missense_Mutation	NA	Y211H	0.13
UCEC	chr20	5117525	Missense_Mutation	novel	G176E	0.36
UCEC	chr20	5119690	Missense_Mutation	NA	L37M	0.28
UCEC	chr20	5115476	Missense_Mutation	NA	L227I	0.39
UCEC	chr20	5117516	Missense_Mutation	novel	N179S	0.37
UCEC	chr20	5114998	3'UTR	novel		0.32
UCEC	chr20	5117614	Silent	novel	R146R	0.24
UCEC	chr20	5115177	3'UTR	novel		0.4
UCEC	chr20	5115287	Missense_Mutation	novel	S261Y	0.39
UCEC	chr20	5117665	Splice_Site	novel	X130_splice	0.36
UCEC	chr20	5115111	3'UTR	novel		0.26
UCEC	chr20	5118670	Missense_Mutation	NA	E109D	0.44
UCEC	chr20	5115304	Silent	rs755609215	I255I	0.27
UCEC	chr20	5119745	Silent	rs773328092	A18A	0.3
UCEC	chr20	5118612	Missense_Mutation	novel	P129S	0.56
UCEC	chr20	5119729	Missense_Mutation	novel	N24D	0.57

Copy Number Variations (CNVs)

Cancer	Type	Freq	Q-value
ACC	DEL	0.1333	0.030954
LUAD	DEL	0.1996	0.15188
TGCT	DEL	0.1867	0.14117

Survival Analysis

Cancer	P-value	Q-value
THYM	0.0062	Kaplan-Meier Survival Analysis
STAD	0.021	Kaplan-Meier Survival Analysis
SARC	0.05	Kaplan-Meier Survival Analysis
MESO	0.00013	Kaplan-Meier Survival Analysis
ACC	0.0025	Kaplan-Meier Survival Analysis
PRAD	0.048	Kaplan-Meier Survival Analysis
ESCA	0.022	Kaplan-Meier Survival Analysis
KIRP	0.0027	Kaplan-Meier Survival Analysis
PAAD	0.0076	Kaplan-Meier Survival Analysis
CESC	0.00071	Kaplan-Meier Survival Analysis
READ	0.0037	Kaplan-Meier Survival Analysis
LAML	0.0093	Kaplan-Meier Survival Analysis
KICH	0.016	Kaplan-Meier Survival Analysis
LIHC	0.00012	Kaplan-Meier Survival Analysis
DLBC	0.017	Kaplan-Meier Survival Analysis
CHOL	0.0099	Kaplan-Meier Survival Analysis
THCA	0.017	Kaplan-Meier Survival Analysis
LUAD	0.013	Kaplan-Meier Survival Analysis
UVM	0.0017	Kaplan-Meier Survival Analysis
OV	0.029	Kaplan-Meier Survival Analysis

Drugs

Cell lines and drugs in GSE70138 or GSE92742

Description

RBPome

Literatures

Expression

Transcripts

Gene Model

Pathways

PPI

Orthologs

Gene Ontology

Description

Ensembl ID: ENSG00000132646 (Gene tree)
Gene ID: 5111
Gene Symbol: PCNA
Alias: N
Full Name: proliferating cell nuclear antigen
Gene Type: protein_coding
Species: Homo_sapiens
Status: confidence
Strand: Minus strand
Length: 11,674 bases
Position: chr20:5,114,953-5,126,626
Accession: 8729
RBP type: non-canonical RBP
Summary: The protein encoded by this gene is found in the nucleus and is a cofactor of DNA polymerase delta. The encoded protein acts as a homotrimer and helps increase the processivity of leading strand synthesis during DNA replication. In response to DNA damage, this protein is ubiquitinated and is involved in the RAD6-dependent DNA repair pathway. Two transcript variants encoding the same protein have been found for this gene. Pseudogenes of this gene have been described on chromosome 4 and on the X chromosome. [provided by RefSeq, Jul 2008]

RNA binding proteome (RBPome)

PID	Title	Method	Time	Author	Doi
30607034	Comprehensive identification of RNA protein interactions in any organism using orthogonal organic phase separation (OOPS)	OOPS & HEK293	2019 Jan 3	Queiroz RML	DOI: 10.1038/s41587-018-0001-2
29431736	Capturing the interactome of newly transcribed RNA	RICK & Hela	2018 Feb 12	Bao X	DOI: 10.1038/nmeth.4595
30607034	Comprehensive identification of RNA protein interactions in any organism using orthogonal organic phase separation (OOPS)	OOPS & MCF10A	2019 Jan 3	Queiroz RML	DOI: 10.1038/s41587-018-0001-2
30607034	Comprehensive identification of RNA protein interactions in any organism using orthogonal organic phase separation (OOPS)	OOPS & U2OS	2019 Jan 3	Queiroz RML	DOI: 10.1038/s41587-018-0001-2

Literatures on RNA binding capacity

PID	Title	Article	Time	Author	Doi
15539445	Molecular markers for the assessment of postnatal male germ cell development in the mouse.	Hum Reprod	2005 Jan	Jarvis S	-
19319956	Increased expression of cellular RNA-binding proteins in HPV-induced neoplasia and cervical cancer.	J Med Virol	2009 May	Fay J	doi: 10.1002/jmv.21406.
18765568	Recruitment of mismatch repair proteins to the site of DNA damage in human cells.	J Cell Sci	2008 Oct 1	Hong Z	doi: 10.1242/jcs.026393
10656792	DNA polymerase switching: II. Replication factor C abrogates primer synthesis by DNA polymerase alpha at a critical length.	J Mol Biol	2000 Jan 28	Mossi R	-
16226712	Proteomic analysis of human O6-methylguanine-DNA methyltransferase by affinity chromatography and tandem mass spectrometry.	Biochem Biophys Res Commun	2005 Dec 2	Niture SK	-
19816296	Recombinant human bone morphogenetic protein-4 (BMP-4)-stimulated cell differentiation and bone formation within the expanding calvarial suture in rats.	J Craniofac Surg	2009 Sep	Shen Q	doi: 10.1097/SCS.0b013e3181b09cc1.
21253613	Proliferating cell nuclear antigen (PCNA) regulates primordial follicle assembly by promoting apoptosis of oocytes in fetal and neonatal mouse ovaries.	PLoS One	2011 Jan 6	Xu B	doi: 10.1371/journal.pone.0016046.
23680657	Syncytial knots (Tenney-Parker changes) in the human placenta: evidence of loss of transcriptional activity and oxidative damage.	Am J Pathol	2013 Jul	Fogarty NM	doi: 10.1016/j.ajpath.2013.03.016
25883228	TIF-IA and Ebp1 regulate RNA synthesis in T cells.	Blood	2015 Apr 16	Saudemont A	doi: 10.1182/blood-2015-03-630780.

Expression

Transcripts

Transcript ID	Name	Length	RefSeq ID	Protein ID	Length	RefSeq ID	UniportKB ID
ENST00000379160	PCNA-202	1359	-	ENSP00000368458	261 (aa)	-	P12004
ENST00000379143	PCNA-201	1344	-	ENSP00000368438	261 (aa)	-	P12004

Gene Model

Click here to download ENSG00000132646's gene model file

Pathways

Pathway ID	Pathway Name	Source
hsa03030	DNA replication	KEGG
hsa03410	Base excision repair	KEGG
hsa03420	Nucleotide excision repair	KEGG
hsa03430	Mismatch repair	KEGG
hsa04110	Cell cycle	KEGG
hsa04530	Tight junction	KEGG
hsa05161	Hepatitis B	KEGG

Protein-Protein Interaction (PPI)

Clik here to download ENSG00000132646's network

* RBP PPI network refers to all genes directly bind to RBP

Orthologs identified by RBPome

Ensembl ID	Gene Symbol	Coverage	Identiy	Ortholog	Gene Symbol	Coverage	Identiy	Species
ENSG00000132646	PCNA	99	47.893	WBGene00003955	pcn-1	99	47.893	Caenorhabditis_elegans
ENSG00000132646	PCNA	99	35.521	YBR088C	POL30	100	35.521	Saccharomyces_cerevisiae

Gene Ontology

Go ID	Go_term	PubmedID	Evidence	Category
GO:0000083	regulation of transcription involved in G1/S transition of mitotic cell cycle	-	TAS	Process
GO:0000701	purine-specific mismatch base pair DNA N-glycosylase activity	11005803.	IDA	Function
GO:0000723	telomere maintenance	-	TAS	Process
GO:0000784	nuclear chromosome, telomeric region	19135898.	HDA	Component
GO:0000785	chromatin	23277426.	IDA	Component
GO:0003682	chromatin binding	23277426.24939902.	IDA	Function
GO:0003684	damaged DNA binding	24939902.	IDA	Function
GO:0005515	protein binding	9305916.10873631.11005803.11022036.14657243.15225546.15358233.15543136.15550930.15576034.15805117.16000169.16189514.16482215.16510448.16826239.17955473.18316726.18499658.18692475.18719106.19150984.19419956.19505873.19730436.20457750.20605778.20733054.20849852.21549307.21628590.21856198.21988832.21994455.22021614.22153967.22634751.22681887.22704558.22705370.22759634.22894931.22902628.23000965.23042605.23042607.23527218.24267889.24561620.24695737.25416956.26496610.26751069.27107012.27906959.28191891.28777577.29290612.29997244.	IPI	Function
GO:0005634	nucleus	21873635.	IBA	Component
GO:0005634	nucleus	15494374.19734146.24939902.	IDA	Component
GO:0005654	nucleoplasm	-	IDA	Component
GO:0005654	nucleoplasm	-	TAS	Component
GO:0005657	replication fork	9774970.	IDA	Component
GO:0005663	DNA replication factor C complex	2565339.	TAS	Component
GO:0005813	centrosome	18331714.	IDA	Component
GO:0006272	leading strand elongation	21873635.	IBA	Process
GO:0006283	transcription-coupled nucleotide-excision repair	-	TAS	Process
GO:0006296	nucleotide-excision repair, DNA incision, 5'-to lesion	-	TAS	Process
GO:0006297	nucleotide-excision repair, DNA gap filling	-	TAS	Process
GO:0006298	mismatch repair	21873635.	IBA	Process
GO:0006298	mismatch repair	11005803.	IDA	Process
GO:0006298	mismatch repair	-	TAS	Process
GO:0006977	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	-	TAS	Process
GO:0007507	heart development	-	IEA	Process
GO:0008283	cell proliferation	2565339.	TAS	Process
GO:0016032	viral process	-	IEA	Process
GO:0016567	protein ubiquitination	-	TAS	Process
GO:0016604	nuclear body	-	IDA	Component
GO:0019899	enzyme binding	24115439.	IPI	Function
GO:0019985	translesion synthesis	21873635.	IBA	Process
GO:0019985	translesion synthesis	20129063.	IDA	Process
GO:0019985	translesion synthesis	-	TAS	Process
GO:0030331	estrogen receptor binding	-	IEA	Function
GO:0030337	DNA polymerase processivity factor activity	21873635.	IBA	Function
GO:0030855	epithelial cell differentiation	21492153.	IEP	Process
GO:0030894	replisome	24115439.	TAS	Component
GO:0030971	receptor tyrosine kinase binding	17115032.	IPI	Function
GO:0031297	replication fork processing	24115439.	ISS	Process
GO:0032077	positive regulation of deoxyribonuclease activity	19443450.	IDA	Process
GO:0032139	dinucleotide insertion or deletion binding	11005803.	IDA	Function
GO:0032201	telomere maintenance via semi-conservative replication	-	TAS	Process
GO:0032355	response to estradiol	-	IEA	Process
GO:0032405	MutLalpha complex binding	11005803.	IDA	Function
GO:0033683	nucleotide-excision repair, DNA incision	-	TAS	Process
GO:0034644	cellular response to UV	24939902.	IDA	Process
GO:0035035	histone acetyltransferase binding	24939902.	IPI	Function
GO:0042276	error-prone translesion synthesis	-	TAS	Process
GO:0042769	DNA damage response, detection of DNA damage	-	TAS	Process
GO:0042802	identical protein binding	15805117.25416956.	IPI	Function
GO:0043596	nuclear replication fork	15543136.21383955.	IDA	Component
GO:0043626	PCNA complex	21873635.	IBA	Component
GO:0043626	PCNA complex	24939902.	IDA	Component
GO:0044849	estrous cycle	-	IEA	Process
GO:0045739	positive regulation of DNA repair	24939902.	IMP	Process
GO:0045740	positive regulation of DNA replication	24939902.	IMP	Process
GO:0046686	response to cadmium ion	-	IEA	Process
GO:0070062	extracellular exosome	20458337.	HDA	Component
GO:0070182	DNA polymerase binding	19995904.24939902.	IPI	Function
GO:0070301	cellular response to hydrogen peroxide	-	IEA	Process
GO:0070557	PCNA-p21 complex	18794347.	IDA	Component
GO:0070987	error-free translesion synthesis	-	TAS	Process
GO:0071548	response to dexamethasone	-	IEA	Process
GO:0097421	liver regeneration	-	IEA	Process
GO:1902065	response to L-glutamate	-	IEA	Process
GO:1902990	mitotic telomere maintenance via semi-conservative replication	24115439.	ISS	Process

EuRBPDB

Note: to get the extension of tumor abbreviations.

Select Dataset :

Input Drug :

Input Cell Line :

Eesembl ID

Cell lines and drugs in GSE70138 or GSE92742

Description

RBPome

Literatures

Expression

Transcripts

Gene Model

Pathways

PPI

Orthologs

Gene Ontology

Note: Click here to get the extension of tumor abbreviations.

Select Dataset :

Input Drug :

Input Cell Line :

Eesembl ID

Cell lines and drugs in GSE70138 or GSE92742

Note: to get the extension of tumor abbreviations.